Mathieu S. Bolhuis

Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB

Saverio De Lorenzo, J. W. C. Alffenaar, Giovanni Sotgiu et al. · European Respiratory Journal · 2012 · 159 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC–MS/MS

Dinh Hoa Vu, Remco A. Koster, Mathieu S. Bolhuis et al. · Talanta · 2014 · 86 citations · Full text

Pharmacy, Pharmaceutical Analysis, Pharmacology +14

Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Linezolid in Patients with Multidrug-Resistant Tuberculosis

Dinh Hoa Vu, Mathieu S. Bolhuis, Remco A. Koster et al. · Antimicrobial Agents and Chemotherapy · 2012 · 81 citations · Full text

Pharmacy, Pharmaceutical Analysis, Pharmacology +16

Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients

Mathieu S. Bolhuis, Richard van Altena, Dick van Soolingen et al. · European Respiratory Journal · 2013 · 67 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Clinical standards for the management of adverse effects during treatment for TB

Kasha P. Singh, Ana Cláudia Carvalho, Rosella Centis et al. · The International Journal of Tuberculosis and Lung Disease · 2023 · 48 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16